Circle8 Group (CIRC) vs Nautilus Biotechnology (NAUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nautilus Biotechnology (NAUT) has outperformed Circle8 Group (CIRC) over the past year, gaining 101.8% versus a loss of 84.9%. Over five years, NAUT leads with a -68.1% price change compared with -99.7% for CIRC. Nautilus Biotechnology is the larger company by market cap ($296.2 million vs $56.4 million), about 5.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CIRC | NAUT |
|---|---|---|
| Share price | $0.48 | $2.33 |
| Market cap | $56.40M | $296.21M |
| 1-day change | +7.62% | +27.90% |
| YTD return | -66.47% | -6.67% |
| 1-year return | -84.93% | +101.77% |
| 5-year return | -99.68% | -68.13% |
| EPS (TTM) | $-2.14 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.56 | $4.31 |
| 52-week low | $0.313 | $0.82 |
| Distance from 52-week high | -89.47% | -45.99% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +64.54% |
| Average volume | 1.79M | 2.66M |
| Shares outstanding | 117.49M | 127.26M |
| Employees | 300 | 127 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nautilus Biotechnology is about 5.3 times larger than Circle8 Group by market value ($296.21M vs $56.40M).
- NAUT has outperformed CIRC by 186.7 percentage points over the past year.
About Circle8 Group
CIRC stock →Circle8 Group, Inc. provides talent management services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 300 employees
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
CIRC vs NAUT FAQ
Which is bigger, Circle8 Group or Nautilus Biotechnology?
Nautilus Biotechnology (NAUT) is larger, with a market capitalization of $296.21M compared with $56.40M for Circle8 Group (CIRC).
Which stock has performed better over the past year, CIRC or NAUT?
NAUT returned +101.77% over the past 12 months, compared with -84.93% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Circle8 Group and Nautilus Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.